Cargando…

Synergistic effects of dendrosomal nanocurcumin and oxaliplatin on oncogenic properties of ovarian cancer cell lines by down-expression of MMPs

BACKGROUND: Contrary to the advantageous anticancer activities of curcumin (Cur), limited bioavailability and solubility hindered its efficacy. Here, nontoxic dendrosomal nano carrier with Cur was used to overcome these problems. Despite considerable antitumor properties of Oxaliplatin (Oxa), the li...

Descripción completa

Detalles Bibliográficos
Autores principales: Seyed Hosseini, Elahe, Alizadeh Zarei, Marziyeh, Tarrahimofrad, Hossein, Zamani, Javad, Haddad Kashani, Hamed, Ahmad, Ejaz, Nikzad, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854214/
https://www.ncbi.nlm.nih.gov/pubmed/36658640
http://dx.doi.org/10.1186/s40659-023-00412-x
_version_ 1784873069103284224
author Seyed Hosseini, Elahe
Alizadeh Zarei, Marziyeh
Tarrahimofrad, Hossein
Zamani, Javad
Haddad Kashani, Hamed
Ahmad, Ejaz
Nikzad, Hossein
author_facet Seyed Hosseini, Elahe
Alizadeh Zarei, Marziyeh
Tarrahimofrad, Hossein
Zamani, Javad
Haddad Kashani, Hamed
Ahmad, Ejaz
Nikzad, Hossein
author_sort Seyed Hosseini, Elahe
collection PubMed
description BACKGROUND: Contrary to the advantageous anticancer activities of curcumin (Cur), limited bioavailability and solubility hindered its efficacy. Here, nontoxic dendrosomal nano carrier with Cur was used to overcome these problems. Despite considerable antitumor properties of Oxaliplatin (Oxa), the limiting factors are drug resistance and adverse side-effects. The hypothesis of this study was to evaluate the possible synergism between dendrosomal nanocurcumin (DNC) and Oxa and these agents showed growth regulatory effects on SKOV3 and OVCAR3 cells. METHODS AND MATERIALS: In the present study, colony formation, wound healing motility, cell adhesion, transwell invasion and migration assay and cell cycle arrest with or without DNC, Oxa and Combination were defined. In addition to, real time PCR and Western blot were used to analyze AKT, PI3K, PKC, JNK, P38 and MMPs mRNAs and proteins expressions. Docking of MMP-2-Cur, MMP-2-DNC and MMP-2-Oxa was performed and the results of all three complexes were simulated by molecular dynamics. RESULTS: Our findings illustrated that DNC had the greatest effect on cell death as compared to the Cur alone. Moreover, the growth inhibitory effects (such as cell death correlated to apoptosis) were more intense if Oxa was added followed by DNC at 4 h interval. However, insignificant effects were observed upon simultaneous addition of these two agents in both cell lines. Besides, a combination of agents synergistically alters the relative expression of MMP-9. CONCLUSIONS: The docking results showed that His70 and Asp100 may play a key role at the MMP-2 binding site. The matrigel invasion as well as cell viability of ovarian cancer cell lines SKOV3 and OVCAR3 by DNC alone or in combination with Oxa was inhibited significantly. The inhibitory effects of these agents were due to the differential expression levels of MMP 2 and MMP 9 regulated by multiple downstream signaling cascades. From the molecular dynamic simulation studies, it was confirmed that DNC established a strong interaction with MMP-2.
format Online
Article
Text
id pubmed-9854214
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98542142023-01-21 Synergistic effects of dendrosomal nanocurcumin and oxaliplatin on oncogenic properties of ovarian cancer cell lines by down-expression of MMPs Seyed Hosseini, Elahe Alizadeh Zarei, Marziyeh Tarrahimofrad, Hossein Zamani, Javad Haddad Kashani, Hamed Ahmad, Ejaz Nikzad, Hossein Biol Res Research Article BACKGROUND: Contrary to the advantageous anticancer activities of curcumin (Cur), limited bioavailability and solubility hindered its efficacy. Here, nontoxic dendrosomal nano carrier with Cur was used to overcome these problems. Despite considerable antitumor properties of Oxaliplatin (Oxa), the limiting factors are drug resistance and adverse side-effects. The hypothesis of this study was to evaluate the possible synergism between dendrosomal nanocurcumin (DNC) and Oxa and these agents showed growth regulatory effects on SKOV3 and OVCAR3 cells. METHODS AND MATERIALS: In the present study, colony formation, wound healing motility, cell adhesion, transwell invasion and migration assay and cell cycle arrest with or without DNC, Oxa and Combination were defined. In addition to, real time PCR and Western blot were used to analyze AKT, PI3K, PKC, JNK, P38 and MMPs mRNAs and proteins expressions. Docking of MMP-2-Cur, MMP-2-DNC and MMP-2-Oxa was performed and the results of all three complexes were simulated by molecular dynamics. RESULTS: Our findings illustrated that DNC had the greatest effect on cell death as compared to the Cur alone. Moreover, the growth inhibitory effects (such as cell death correlated to apoptosis) were more intense if Oxa was added followed by DNC at 4 h interval. However, insignificant effects were observed upon simultaneous addition of these two agents in both cell lines. Besides, a combination of agents synergistically alters the relative expression of MMP-9. CONCLUSIONS: The docking results showed that His70 and Asp100 may play a key role at the MMP-2 binding site. The matrigel invasion as well as cell viability of ovarian cancer cell lines SKOV3 and OVCAR3 by DNC alone or in combination with Oxa was inhibited significantly. The inhibitory effects of these agents were due to the differential expression levels of MMP 2 and MMP 9 regulated by multiple downstream signaling cascades. From the molecular dynamic simulation studies, it was confirmed that DNC established a strong interaction with MMP-2. BioMed Central 2023-01-20 /pmc/articles/PMC9854214/ /pubmed/36658640 http://dx.doi.org/10.1186/s40659-023-00412-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Seyed Hosseini, Elahe
Alizadeh Zarei, Marziyeh
Tarrahimofrad, Hossein
Zamani, Javad
Haddad Kashani, Hamed
Ahmad, Ejaz
Nikzad, Hossein
Synergistic effects of dendrosomal nanocurcumin and oxaliplatin on oncogenic properties of ovarian cancer cell lines by down-expression of MMPs
title Synergistic effects of dendrosomal nanocurcumin and oxaliplatin on oncogenic properties of ovarian cancer cell lines by down-expression of MMPs
title_full Synergistic effects of dendrosomal nanocurcumin and oxaliplatin on oncogenic properties of ovarian cancer cell lines by down-expression of MMPs
title_fullStr Synergistic effects of dendrosomal nanocurcumin and oxaliplatin on oncogenic properties of ovarian cancer cell lines by down-expression of MMPs
title_full_unstemmed Synergistic effects of dendrosomal nanocurcumin and oxaliplatin on oncogenic properties of ovarian cancer cell lines by down-expression of MMPs
title_short Synergistic effects of dendrosomal nanocurcumin and oxaliplatin on oncogenic properties of ovarian cancer cell lines by down-expression of MMPs
title_sort synergistic effects of dendrosomal nanocurcumin and oxaliplatin on oncogenic properties of ovarian cancer cell lines by down-expression of mmps
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854214/
https://www.ncbi.nlm.nih.gov/pubmed/36658640
http://dx.doi.org/10.1186/s40659-023-00412-x
work_keys_str_mv AT seyedhosseinielahe synergisticeffectsofdendrosomalnanocurcuminandoxaliplatinononcogenicpropertiesofovariancancercelllinesbydownexpressionofmmps
AT alizadehzareimarziyeh synergisticeffectsofdendrosomalnanocurcuminandoxaliplatinononcogenicpropertiesofovariancancercelllinesbydownexpressionofmmps
AT tarrahimofradhossein synergisticeffectsofdendrosomalnanocurcuminandoxaliplatinononcogenicpropertiesofovariancancercelllinesbydownexpressionofmmps
AT zamanijavad synergisticeffectsofdendrosomalnanocurcuminandoxaliplatinononcogenicpropertiesofovariancancercelllinesbydownexpressionofmmps
AT haddadkashanihamed synergisticeffectsofdendrosomalnanocurcuminandoxaliplatinononcogenicpropertiesofovariancancercelllinesbydownexpressionofmmps
AT ahmadejaz synergisticeffectsofdendrosomalnanocurcuminandoxaliplatinononcogenicpropertiesofovariancancercelllinesbydownexpressionofmmps
AT nikzadhossein synergisticeffectsofdendrosomalnanocurcuminandoxaliplatinononcogenicpropertiesofovariancancercelllinesbydownexpressionofmmps